Contact this trialFirst, we need to learn more about you.
124I-cG250 Imaging for Kidney Cancer Response Detection
Recruiting1 award8 criteria
New York, New York
This trial will test whether 124I-cG250 PET/CT can show if sunitinib or pazopanib is working against kidney cancer sooner than a regular CT scan.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.